Search

Your search keyword '"Aust, D"' showing total 29 results
Start Over Author "Aust, D" Journal zeitschrift fur gastroenterologie
29 results on '"Aust, D"'

1. Aktualisierte S2k-Leitlinie Zöliakie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

Author

Felber, Jörg, primary, Schumann, Michael, primary, Bläker, Hendrik, additional, Fischbach, Wolfgang, additional, Koletzko, Sibylle, additional, Laaß, Martin, additional, Lachmann, Nils, additional, Lorenz, Pia, additional, Lynen, Petra, additional, Reese, Imke, additional, Scherf, Katharina, additional, Schuppan, Detlef, additional, Aust, D., additional, Baas, S., additional, Beisel, S., additional, de Laffolie, J., additional, Duba, E., additional, Holtmeier, W., additional, Lange, L., additional, Loddenkemper, C., additional, Moog, G., additional, Rath, T., additional, Roeb, E., additional, Rubin, D., additional, Stein, J., additional, Török, H., additional, and Zopf, Y., additional

Published
2022
Full Text
View/download PDF

7. Ergebnisse einer S2k-Konsensuskonferenz der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen (DGVS) gemeinsam mit der Deutschen Zöliakie-Gesellschaft (DZG) zur Zöliakie, Weizenallergie und Weizensensitivität

Author

Felber, J., additional, Aust, D., additional, Baas, S., additional, Bischoff, S., additional, Bläker, H., additional, Daum, S., additional, Keller, R., additional, Koletzko, S., additional, Laass, M., additional, Nothacker, M., additional, Roeb, E., additional, Schuppan, D., additional, and Stallmach, A., additional

Published
2014
Full Text
View/download PDF

10. Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer Evidenzbasierten Konsensuskonferenz

Author

Dignass, A., primary, Preiß, J., additional, Aust, D., additional, Autschbach, F., additional, Ballauff, A., additional, Barretton, G., additional, Bokemeyer, B., additional, Fichtner-Feigl, S., additional, Hagel, S., additional, Herrlinger, K., additional, Jantschek, G., additional, Kroesen, A., additional, Kruis, W., additional, Kucharzik, T., additional, Langhorst, J., additional, Reinshagen, M., additional, Rogler, G., additional, Schleiermacher, D., additional, Schmidt, C., additional, Schreiber, S., additional, Schulze, H., additional, Stange, E., additional, Zeitz, M., additional, Hoffmann, J., additional, and Stallmach, A., additional

Published
2011
Full Text
View/download PDF

15. S3-Leitlinie „Magenkarzinom” -

Author

Moehler, M., primary, Al-Batran, S.-E., additional, Andus, T., additional, Anthuber, M., additional, Arends, J., additional, Arnold, D., additional, Aust, D., additional, Baier, P., additional, Baretton, G., additional, Bernhardt, J., additional, Boeing, H., additional, Böhle, E., additional, Bokemeyer, C., additional, Bornschein, J., additional, Budach, W., additional, Burmester, E., additional, Caca, K., additional, Diemer, W., additional, Dietrich, C., additional, Ebert, M., additional, Eickhoff, A., additional, Ell, C., additional, Fahlke, J., additional, Feußner, H., additional, Fietkau, R., additional, Fischbach, W., additional, Fleig, W., additional, Flentje, M., additional, Gabbert, H., additional, Galle, P., additional, Geissler, M., additional, Gockel, I., additional, Graeven, U., additional, Grenacher, L., additional, Groß, S., additional, Hartmann, J., additional, Heike, M., additional, Heinemann, V., additional, Herbst, B., additional, Herrmann, T., additional, Höcht, S., additional, Hofheinz, R., additional, Höfler, H., additional, Höhler, T., additional, Hölscher, A., additional, Horneber, M., additional, Hübner, J., additional, Izbicki, J., additional, Jakobs, R., additional, Jenssen, C., additional, Kanzler, S., additional, Keller, M., additional, Kiesslich, R., additional, Klautke, G., additional, Körber, J., additional, Krause, B., additional, Kuhn, C., additional, Kullmann, F., additional, Lang, H., additional, Link, H., additional, Lordick, F., additional, Ludwig, K., additional, Lutz, M., additional, Mahlberg, R., additional, Malfertheiner, P., additional, Merkel, S., additional, Messmann, H., additional, Meyer, H.-J., additional, Mönig, S., additional, Piso, P., additional, Pistorius, S., additional, Porschen, R., additional, Rabenstein, T., additional, Reichardt, P., additional, Ridwelski, K., additional, Röcken, C., additional, Roetzer, I., additional, Rohr, P., additional, Schepp, W., additional, Schlag, P., additional, Schmid, R., additional, Schmidberger, H., additional, Schmiegel, W.-H., additional, Schmoll, H.-J., additional, Schuch, G., additional, Schuhmacher, C., additional, Schütte, K., additional, Schwenk, W., additional, Selgrad, M., additional, Sendler, A., additional, Seraphin, J., additional, Seufferlein, T., additional, Stahl, M., additional, Stein, H., additional, Stoll, C., additional, Stuschke, M., additional, Tannapfel, A., additional, Tholen, R., additional, Thuss-Patience, P., additional, Treml, K., additional, Vanhoefer, U., additional, Vieth, M., additional, Vogelsang, H., additional, Wagner, D., additional, Wedding, U., additional, Weimann, A., additional, Wilke, H., additional, and Wittekind, C., additional

Published
2011
Full Text
View/download PDF

24. [Chronic or severe enteropathy and immunodeficiency: be prepared for a rara avis].

Author

Weber K, Zeißig Y, Haag C, Schmelz R, Pazmandi J, Kalinichenko A, Boztug K, Zeißig S, Aust D, Laass MW, and Schuetz C

Subjects
Humans, Inflammation, Inflammatory Bowel Diseases diagnosis, Inflammatory Bowel Diseases therapy
Abstract

In the work-up of chronic enteropathies an underlying inborn error of immunity (IEI) should be considered in certain cases. IEI are rare, but approximately 10% of patients may present with symptoms of inflammatory bowel disease (IBD), which is a much more common entity. Patients with IEI associated IBD may show extraintestinal symptoms or signs, and are often refractory to conventional anti-inflammatory treatment. In case of early-onset bowel inflammation and other intestinal or extraintestinal manifestations, an IEI should be excluded. A small fraction of monogenic IEI can be amenable to targeted therapies, or even corrected by allogeneic stem cell transplantation. Therefore, early diagnosis is crucial. This paper shows examples of clinical - gastrointestinal as well as extraintestinal - signs and findings which require immunological and possibly genetic workup., Competing Interests: Die Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht., (Thieme. All rights reserved.)

Published
2022
Full Text
View/download PDF

25. [Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in conjunction with the German Coeliac Society (DZG) regarding coeliac disease, wheat allergy and wheat sensitivity].

Author

Felber J, Aust D, Baas S, Bischoff S, Bläker H, Daum S, Keller R, Koletzko S, Laass M, Nothacker M, Roeb E, Schuppan D, and Stallmach A

Subjects
Germany, Humans, Allergy and Immunology standards, Celiac Disease diagnosis, Celiac Disease therapy, Gastroenterology standards, Practice Guidelines as Topic, Wheat Hypersensitivity diagnosis, Wheat Hypersensitivity therapy
Published
2014
Full Text
View/download PDF

26. [Microscopic colitis--new insights relevant to clinical practice].

Author

Miehlke S, Aust D, and Madisch A

Subjects
Colitis, Microscopic classification, Diagnosis, Differential, Humans, Anti-Inflammatory Agents therapeutic use, Budesonide therapeutic use, Colitis, Microscopic diagnosis, Colitis, Microscopic drug therapy, Practice Patterns, Physicians'
Abstract

Microscopic colitis is an increasingly recognised chronic inflammatory bowel disease associated with watery, non-bloody diarrhoea. In addition, many patients suffer from abdominal pain, nocturnal diarrhoea, urgency and incontinence. The two traditional histological subtypes are collagenous colitis and lymphocytic colitis. A novel third subgroup is the so-called incomplete microscopic colitis which is clinically indistinguishable. At present, budesonide is the only evidenced-based effective therapy, however many problems in the long-term treatment strategy are still unsolved. The present paper reviews new developments in microscopic colitis which are relevant for clinical practice., (© Georg Thieme Verlag KG Stuttgart · New York.)

Published
2013
Full Text
View/download PDF

27. [Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].

Author

Dignass A, Preiss JC, Aust DE, Autschbach F, Ballauff A, Barretton G, Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, and Stallmach A

Subjects
Colonoscopy, Germany, Humans, Colitis, Ulcerative diagnosis, Colitis, Ulcerative therapy
Published
2011
Full Text
View/download PDF

28. [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Author

Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, and Wittekind C

Subjects
Germany, Humans, Esophageal Neoplasms diagnosis, Esophageal Neoplasms therapy, Gastroenterology standards, Stomach Neoplasms diagnosis, Stomach Neoplasms therapy
Published
2011
Full Text
View/download PDF

29. [Pitfalls in diagnosis of celiac disease].

Author

Henker J, Laass M, Baretton G, Fischer R, and Aust D

Subjects
Celiac Disease immunology, Diagnosis, Differential, Humans, IgA Deficiency immunology, Celiac Disease blood, Celiac Disease diagnosis, Diagnostic Errors prevention & control, IgA Deficiency blood, IgA Deficiency diagnosis, Serologic Tests, Transglutaminases blood
Abstract

Both serology and histology remain cornerstones in the diagnosis of coeliac disease. IgA class antibodies against tissue transglutaminase and endomysium have the highest specificity and sensitivity in comparison with other serological tests. An IgA deficiency in serum must always be excluded. Antigliadin antibodies have, because of their low positive predictive value apart from in early childhood, no value as a diagnostic tool in coeliac disease. Intestinal biopsies should be evaluated according to the revised Marsh criteria. A discrepancy between serology and histology requires a competent evaluation by a gastroenterologist and, if necessary, further diagnostic procedures.

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results